HK1198535A1 - -氨基苯基 -烷基- -二氫- 噁嗪- -胺衍生物 - Google Patents

-氨基苯基 -烷基- -二氫- 噁嗪- -胺衍生物

Info

Publication number
HK1198535A1
HK1198535A1 HK14112018.7A HK14112018A HK1198535A1 HK 1198535 A1 HK1198535 A1 HK 1198535A1 HK 14112018 A HK14112018 A HK 14112018A HK 1198535 A1 HK1198535 A1 HK 1198535A1
Authority
HK
Hong Kong
Prior art keywords
oxazin
aminophenyl
dihydro
alkyl
amine derivatives
Prior art date
Application number
HK14112018.7A
Other languages
English (en)
Inventor
Henricus Jacobus Maria Gijsen
Sven Franciscus Anna Van Brandt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of HK1198535A1 publication Critical patent/HK1198535A1/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK14112018.7A 2011-12-06 2014-11-28 -氨基苯基 -烷基- -二氫- 噁嗪- -胺衍生物 HK1198535A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11192171 2011-12-06
PCT/EP2012/074349 WO2013083556A1 (en) 2011-12-06 2012-12-04 5-(3-aminophenyl)-5-alkyl-5,6-dihydro-2h-[1,4]oxazin-3-amine derivatives

Publications (1)

Publication Number Publication Date
HK1198535A1 true HK1198535A1 (zh) 2015-05-15

Family

ID=47278316

Family Applications (1)

Application Number Title Priority Date Filing Date
HK14112018.7A HK1198535A1 (zh) 2011-12-06 2014-11-28 -氨基苯基 -烷基- -二氫- 噁嗪- -胺衍生物

Country Status (13)

Country Link
US (1) US20140364428A1 (zh)
EP (1) EP2788335B1 (zh)
JP (1) JP5989130B2 (zh)
KR (1) KR102002345B1 (zh)
CN (1) CN103974940B (zh)
AU (1) AU2012347396B2 (zh)
CA (1) CA2853891C (zh)
EA (1) EA024716B1 (zh)
ES (1) ES2582473T3 (zh)
HK (1) HK1198535A1 (zh)
IL (1) IL232917A (zh)
MX (1) MX357383B (zh)
WO (1) WO2013083556A1 (zh)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ589590A (en) 2008-06-13 2012-05-25 Shionogi & Co Sulfur-containing heterocyclic derivative having beta-secretase-inhibiting activity
RU2012129168A (ru) 2009-12-11 2014-01-20 Сионоги Энд Ко. Лтд. Производные оксазина
CA2799640C (en) 2010-06-09 2018-10-16 Janssen Pharmaceutica Nv 5,6-dihydro-2h-[1,4]oxazin-3-yl-amine derivatives useful as inhibitors of beta-secretase (bace)
ES2648143T3 (es) 2010-12-22 2017-12-28 Janssen Pharmaceutica Nv Derivados de 5,6-dihidro-imidazo[1,2-a]pirazin-8-ilamina útiles como inhibidores de la beta-secretasa (BACE)
JP5853035B2 (ja) 2011-03-09 2016-02-09 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプJanssen Pharmaceutica Naamloze Vennootschap β−セクレターゼ(BACE)の阻害剤として有用な3,4−ジヒドロ−ピロロ[1,2−a]ピラジン−1−イルアミン誘導体
UA111749C2 (uk) * 2011-12-05 2016-06-10 Янссен Фармацевтика Нв Похідні 6-дифторметил-5,6-дигідро-2h-[1,4]оксазин-3-аміну
EP2912035A4 (en) 2012-10-24 2016-06-15 Shionogi & Co DERIVATIVES OF DIHYDROOXAZINE OR OXAZEPINE HAVING BACE1 INHIBITING ACTIVITY
BR112015030597A2 (pt) 2013-06-12 2017-07-25 Janssen Pharmaceutica Nv derivados 4-amino-6-fenil-6,7-di-hidro[1,2,3]triazolo[1,5-a]pirazina como inibidores de beta-secretase (bace)
US9580433B2 (en) 2013-06-12 2017-02-28 Janssen Pharmaceutica Nv 4-amino-6-phenyl-5,6-dihydroimidazo[1,5-A]pyrazine derivatives as inhibitors of beta-secretase (BACE)
MX368326B (es) 2013-06-12 2019-09-27 Janssen Pharmaceutica Nv Derivados de 4-amino-6-fenil-5,6-dihidroimidazo[1,5-a]pirazin-3(2h )-ona como inhibidores de beta-secretasa (bace).
ES2768823T3 (es) 2014-12-18 2020-06-23 Janssen Pharmaceutica Nv Derivados de 2,3,4,5-tetrahidropiridin-6-amina y 3,4-dihidro-2H-pirrol-5-amina útiles como inhibidores de beta-secretasa
JP2020503300A (ja) * 2016-12-16 2020-01-30 ヤンセン ファーマシューティカ エヌ.ベー. 二環式oga阻害剤化合物
WO2019025250A1 (en) 2017-08-04 2019-02-07 Basf Se SUBSTITUTED TRIFLUOROMETHYLOXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI
CN108440320A (zh) * 2018-05-09 2018-08-24 上海凌凯医药科技有限公司 一种高手性选择性合成α-双取代α-氨基酸的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2476605T3 (es) * 2007-04-24 2014-07-15 Shionogi & Co., Ltd. Derivados de aminohidrotiazina sustituidos con grupos cíclicos
WO2008133273A1 (ja) * 2007-04-24 2008-11-06 Shionogi & Co., Ltd. アルツハイマー症治療用医薬組成物
UY32799A (es) * 2009-07-24 2011-02-28 Novartis Ag Derivados de oxazina y su uso en el tratamiento de trastornos neurológicos
US8188079B2 (en) * 2009-08-19 2012-05-29 Hoffman-La Roche Inc. 3-amino-5-phenyl-5,6-dihydro-2H-[1,4]oxazines
WO2011058763A1 (ja) * 2009-11-13 2011-05-19 塩野義製薬株式会社 アミノリンカーを有するアミノチアジンまたはアミノオキサジン誘導体
RU2012129168A (ru) * 2009-12-11 2014-01-20 Сионоги Энд Ко. Лтд. Производные оксазина
CA2799640C (en) * 2010-06-09 2018-10-16 Janssen Pharmaceutica Nv 5,6-dihydro-2h-[1,4]oxazin-3-yl-amine derivatives useful as inhibitors of beta-secretase (bace)
US9242943B2 (en) * 2011-01-18 2016-01-26 Siena Biotech S.P.A. 1,4 oxazines as BACE1 and/or BACE2 inhibitors
CN103987710A (zh) * 2011-10-13 2014-08-13 诺华股份有限公司 新的*嗪衍生物及它们在治疗疾病中的应用
UA111749C2 (uk) * 2011-12-05 2016-06-10 Янссен Фармацевтика Нв Похідні 6-дифторметил-5,6-дигідро-2h-[1,4]оксазин-3-аміну

Also Published As

Publication number Publication date
ES2582473T3 (es) 2016-09-13
EA024716B1 (ru) 2016-10-31
EP2788335B1 (en) 2016-04-13
IL232917A (en) 2016-07-31
AU2012347396A1 (en) 2014-05-08
CA2853891C (en) 2020-03-10
CN103974940A (zh) 2014-08-06
EP2788335A1 (en) 2014-10-15
US20140364428A1 (en) 2014-12-11
CA2853891A1 (en) 2013-06-13
MX357383B (es) 2018-07-06
CN103974940B (zh) 2016-08-24
KR102002345B1 (ko) 2019-07-22
WO2013083556A1 (en) 2013-06-13
JP2015500257A (ja) 2015-01-05
IL232917A0 (en) 2014-08-03
EA201491102A1 (ru) 2014-09-30
NZ623858A (en) 2015-05-29
AU2012347396B2 (en) 2017-02-16
KR20140106541A (ko) 2014-09-03
JP5989130B2 (ja) 2016-09-07
MX2014006752A (es) 2014-07-14

Similar Documents

Publication Publication Date Title
HK1198535A1 (zh) -氨基苯基 -烷基- -二氫- 噁嗪- -胺衍生物
AP2013007254A0 (en) 4-Aryl-N-phenyl-1,3,5,-triazin-2-amines containinga sulfoximine group
ZA201205788B (en) 1,2,4-triazine-4-amine derivatives
EP2762476A4 (en) 1,2,4-triazine-6-carboxamide derivative
HK1215376A1 (zh) 取代的 -氟- -亞氨基- -甲基- -氧代- -二氫嘧啶- -甲醯胺衍生物
SI2694508T1 (sl) Soli substituiranega 2,3-dihidroimidazo(1,2-C)kinazolina
EP2679730A4 (en) Construction machine
IL227664A0 (en) New heterocyclic histories
EP2699091A4 (en) 2 ', 6'-dioxo-3'-deutero-PIPERIDIN-3-YL-isoindoline COMPOUNDS
EP2664715A4 (en) Construction machine
HK1198586A1 (zh) -二氟甲基- -二氫- 噁嗪- -胺衍生物
HK1202288A1 (zh) -氧代-噁唑烷- -二基抗生素衍生物
HK1192757A1 (zh) 取代的 -芳基- -苯基- -三嗪- -胺
HK1191653A1 (zh) -糖苷衍生物
PL2912030T3 (pl) Ulepszony sposób wytwarzania 5-(2,6-di-4-morfolinylo-4-pirymidynylo)-4- trifluorometylopirydyno-2-aminy
EP2674310A4 (en) Construction machine
EP2675773A4 (en) PROCESS FOR THE PREPARATION OF CIS-1-CHLORO-3,3,3-TRIFLUOROPROPENE
IL231468A0 (en) 3,1-diaryl-converted heterocyclic pesticides
EP2679729A4 (en) Construction machine
HK1201150A1 (zh) -{ -羥基- -{ -二甲基氨基甲基 苯並呋喃- -基羰基氨基 乙氧基}苯甲酰胺的給藥方案
EP2794806A4 (en) AZEOTROPÄHNLICHE COMPOSITIONS WITH CIS-1-CHLORO-3,3,3-TRIFLUORPROPEN
MY165626A (en) 1,2,4,-triazolone derivative
IL233001A0 (en) New iso-ergoline histories
AU2011900143A0 (en) Swaging machine
GB201115337D0 (en) Seasontickethub.com

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20221202